Page last updated: 2024-08-24

fluorodeoxyglucose f18 and ro5126766

fluorodeoxyglucose f18 has been researched along with ro5126766 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carlier, T; Chua, S; Gleeson, F; Hugonnet, F; Kraeber-Bodéré, F; Lumbroso, J; Naegelen, VM; Nagarajah, J; Shochat, E; Stokkel, M; Tessier, J; Trampal, C	1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and ro5126766

Article	Year
Differences in the biologic activity of 2 novel MEK inhibitors revealed by 18F-FDG PET: analysis of imaging data from 2 phase I trials. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:12 Topics: Adult; Aged; Benzamides; Clinical Trials, Phase I as Topic; Coumarins; Extracellular Signal-Regulated MAP Kinases; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Neoplasms; Oxazines; Phosphoproteins; Positron-Emission Tomography; Protein Kinase Inhibitors; Treatment Failure; Young Adult	2012

Article

Year

Differences in the biologic activity of 2 novel MEK inhibitors revealed by 18F-FDG PET: analysis of imaging data from 2 phase I trials.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:12

Topics: Adult; Aged; Benzamides; Clinical Trials, Phase I as Topic; Coumarins; Extracellular Signal-Regulated MAP Kinases; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Neoplasms; Oxazines; Phosphoproteins; Positron-Emission Tomography; Protein Kinase Inhibitors; Treatment Failure; Young Adult

2012